Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06232304 · ClinicalTrials.gov registry record · NA
Transforming Care for Individuals With Childhood-onset Systemic Lupus Erythematosus
A NA study of Systemic Lupus Erythematosus of Childhood (Disorder), sponsored by Michigan State University.
- Recruiting
- Registry status
- NA
- Development phase
- 175
- Enrollment target
- 7
- Study locations
NCT06232304: Recruiting NA study of Systemic Lupus Erythematosus of Childhood (Disorder), sponsored by Michigan State University.
NCT06232304 is a NA study of Systemic Lupus Erythematosus of Childhood (Disorder) that is actively recruiting participants, run by Michigan State University. The registered enrollment target is 175 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (88% lower). The trial reports 7 study locations across 7 states. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT06232304, a NA study of Systemic Lupus Erythematosus of Childhood (Disorder), is actively recruiting participants, sponsored by Michigan State University.
- RECRUITING
- Registry status
- NA
- Development phase
- 175 participants
- Enrollment target
- 7
- Study locations
Study Summary
This study aims to investigate the feasibility and effectiveness of a cognitive behavioral coping skills program, Treatment and Education Approach for Childhood-onset Lupus (TEACH), for youth with cSLE when integrated into medical care. This TEACH program aims to teach participants skills in order to cope with fatigue, pain, and depressive symptoms--symptoms that commonly affect adolescents and young adults with lupus.
Primary Outcome
The CDI-2 measures depressive symptoms on a scale of 0-54, with 0 indicating low levels of depressive symptoms, and 54 indicating high levels of depressive symptoms. The BDI-II measures depressive symptoms on a scale of 0 to 63, with 0 indicating low levels of depressive symptoms and 63 indicating high levels of depressive symptoms.
Conditions Studied
Interventions
- BEHAVIORAL TEACH
Study Locations (7)
Alabama
- University of Alabama Birmingham Hospital - Birmingham
Louisiana
- Children's Hospital of New Orleans/ Tulane University - New Orleans
Michigan
- Helen Devos Children's Hospital - Grand Rapids
New York
- Montefiore Medical Center - The Bronx
Ohio
- Cincinnati Children's Hospital Medical Center - Cincinnati
Washington
- Seattle Children's Hospital - Seattle
Ontario
- The Hospital for Sick Children - Toronto
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 175 participants |
| Start Date | 2024-09-12 |
| Est. Completion | 2027-09-30 |
| Phase | NA |
What NCT06232304 shows while recruiting
NCT06232304 is an interventional study that assigns participants to a tested intervention. The registered 175 participants enrollment target is mid-sized for trials with a published cap, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (88% lower).
The record links to 1 condition, with Systemic Lupus Erythematosus of Childhood (Disorder) appearing as the primary indexed condition, and to 1 intervention - of which TEACH is the first listed.
NCT06232304 lists 7 locations in 7 states (Alabama, Louisiana, Michigan).
Frequently Asked Questions
What is clinical trial NCT06232304 about?
NCT06232304 is a clinical study titled "Transforming Care for Individuals With Childhood-onset Systemic Lupus Erythematosus". This study aims to investigate the feasibility and effectiveness of a cognitive behavioral coping skills program, Treatment and Education Approach for Childhood-onset Lupus (TEACH), for youth with cSLE when integrated into medical care. This TEACH program aims to teach participants skills in order t...
What is the current status of trial NCT06232304?
This trial is currently recruiting. It is a NA study. The enrollment target is 175 participants. The study started on 2024-09-12. Estimated completion is 2027-09-30.
What conditions does trial NCT06232304 study?
This clinical trial studies the following conditions: Systemic Lupus Erythematosus of Childhood (Disorder).
What interventions are being tested in trial NCT06232304?
The interventions under investigation include: TEACH (BEHAVIORAL).
Who is sponsoring clinical trial NCT06232304?
This trial is sponsored by Michigan State University, which has 120 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT06232304 being conducted?
This trial has 7 study locations across Alabama, Louisiana, Michigan, New York, Ohio. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT06232304's enrollment target sits among peer trials
175 610th of 2000 higher than 1,391 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT04722341 · 175 participants · NA
Time-Restricted Eating and Cancer: Clinical Outcomes, Mechanisms, and Moderators
- NCT05094037 · 175 participants · NA
Orthotic Treatment of Diabetic Foot Ulcers
- NCT05165745 · 175 participants · NA
Stick2PrEP Cisgender Women and Trans Individuals
- NCT05312255 · 175 participants · NA
Non-chemotherapeutic Interventions for the Improvement of Quality of Life and Immune Function in Patients With Multiple Myeloma
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI